A prospective non-comparative study to assess the effectiveness and safety of combination laxative therapy containing milk of magnesia, liquid paraffin and sodium picosulphate (Cremaffin-Plus®) in the management of constipation in patients with anal fissure/hemorrhoids/obstructive defecation syndrome
DOI:
https://doi.org/10.18203/2349-2902.isj20175160Keywords:
Anal fissure, Constipation, Hemorrhoids, Milk of magnesia, Obstructive defecation syndrome, PAC-QoL, Sodium picosulphateAbstract
Background: Assess the effectiveness and safety of combination laxative therapy containing milk of magnesia, liquid paraffin and sodium picosulphate (Cremaffin-Plus®) in management of constipation, in patients with anal fissure/haemorrhoids/obstructive defecation syndrome (ODS).
Methods: Patients visiting study site with complaints of constipation secondary to anal fissures/haemorrhoids/ODS, intended to receive combination laxative therapy (as per physicians’ discretion), were enrolled. Primary objectives were to assess the change in number of bowel movements per day and stool consistency; secondary objectives were to assess change in straining, physician global efficacy assessment, quality of life (PAC-QOL score), Constipation Symptoms (CSS), Fecal Incontinence Score (FIS), Patient Assessment of Constipation Symptoms (PAC-SYM) score, along with the Modified Longo Score (MODS) for ODS from baseline to end of 4 weeks. Safety, tolerability and treatment adherence were also assessed.
Results: About 32 patients (anal fissure:19, haemorrhoids:5, ODS:8) met inclusion criteria. Significant improvement in stool frequency was observed in all patients pooled together (p=0.016); group wise, statistical significance was noted in patients of anal fissures. Stool consistency was improved in all patients pooled together (p<0.001); group wise, significant improvement was seen in patients of anal fissure and ODS. There was a significant improvement in straining noted in all patients pooled together (p=0.002). Significant reduction (p<0.001) was noted in all the symptom scores (CSS, FIS, PAC-SYM and PAC-QOL) from baseline to 4 weeks in all patients. About 51.44% reduction in MODS score was noted in patients with ODS.
Conclusions: Improvement in stool frequency, consistency and straining was noted in all patients with constipation (with fissure/haemorrhoids/ODS) treated with Cremaffin-plus for 4-weeks, improving the quality of life. All patients showed good therapy adherence with better safety and tolerability profile.
References
Surrenti E, Rath DM, Pemberton JH, Camilleri M. Audit of constipation in a tertiary referral gastroenterology practice. Am J Gastroenterol. 1995;90(9):1471-5.
Lembo A, Camilleri M. Chronic constipation. N Engl J Med. 2003;349(14):1360-8.
Bharucha AE. American Gastroenterological Association Medical Position Statement on Constipation. Gastroenterol. 2013;144:211-7.
Ellis CN, Essani R. Treatment of obstructed defecation. Clin Colon Rectal Surg. 2012;25(1):24-33.
Kinnunen O, Salokannel J. Constipation in elderly long-stay patients: its treatment by magnesium hydroxide and bulk-laxative. Ann Clin Res. 1987;19(5):321-3.
Sharif F, Crushell E, O’Driscoll K, Bourke B. Liquid paraffin: a reappraisal of its role in the treatment of constipation. Arch Dis Child. 2001;85(2):121-4.
Hoy S, Scott L, Wagstaff A. Sodium picosulfate/magnesium citrate: a review of its use as a colorectal cleanser. Drugs. 2009;69(1):123-36.
Kienzle-Horn S, Vix J-M, Schuijt C, Peil H, Jordan CC, Kamm MA. Comparison of bisacodyl and sodium picosulphate in the treatment of chronic constipation. Curr Med Res Opin. 2007;23(4):691-9.
MOHFW (Govt. of India). Drugs and Cosmetics (Third Amendment) Rules. New Delhi: Govt. of India; 2014 p. G.S.R. 292 (E). Available at http://www.cdsco.nic.in/forms/list.aspx?lid=1833&Id=31.
ICMR (Govt. of India). Ethical Guidelines for Biomedical Research on Human Participants. India; 2006. Available at http://icmr.nic.in/ethical_guidelines.pdf.
Constipation Treatment [Internet]. World Gastroenterology Institute - Hospital for Digestive Diseases. [cited 2017 Oct 10]. Available at http://www.wgi.ooo/Constipation.aspx
CADTH. Treatments for Constipation: A Review of Systematic Reviews. Canadian Agency for Drugs and Technologies in Health [CADTH] Rapid Response Reports. 2014. Available at https://www.cadth.ca/treatments-constipation-review-systematic-reviews.
Gallagher PF, O’Mahony D, Quigley EMM. Management of chronic constipation in the elderly. Drugs Aging. 2008;25(10):807-21.
Tack J, Müller-Lissner S, Stanghellini V, Boeckxstaens G, Kamm MA, Simren M, et al. Diagnosis and treatment of chronic constipation--a European perspective. Neurogastroenterol Motil. 2011;23(8):697-710.
Jamshed N. Diagnostic Approach to Chronic Constipation in Adults. Am Fam Physician. 2011;84(3):299-306.
Schlichtemeier S. Anal fissure. Aust Prescr. 2016;39(1):14-7.
Rooprai R, Bhat N, Sainani R, Mayabhate MM. Prevalence of functional constipation and constipation-predominant irritable bowel syndrome in Indian patients with constipation. Int J Basic Clin Pharmacol. 2017;6:275-85.
Wulkow R, Vix J-M, Schuijt C, Peil H, Kamm MA, Jordan C. Randomised, placebo-controlled, double-blind study to investigate the efficacy and safety of the acute use of sodium picosulphate in patients with chronic constipation. Int J Clin Pract. 2007;61(6):944-50.
Thapar RB, Patankar R V, Kamat RD, Thapar RR, Chemburkar V. MR defecography for obstructed defecation syndrome. Indian J Radiol Imaging. 2015;25(1):25-30.
Rashid A, Khuroo S. Obstructed Defecation Syndrome: A Treatise on Its Functional Variant. Intern Med. 2014;(S1):1-4.
Pucciani F. A theory of progression from obstructed defecation to fecal incontinence. Tech Coloproctol. 2015;19(12):713-5.
